Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone vs. Endocrine Therapy Alone or Combined Treatment for Low-Risk ER-positive Early-Stage Breast Cancer in Women Age 65 and Older
CONCLUSIONS: U-WBI alone appears the more cost-effective de-escalation strategy for these patients, compared to AI alone. Combining U-WBI and AI appears more costly but may be preferred by some patients.PMID:36586492 | DOI:10.1016/j.ijrobp.2022.12.028
Source: Health Physics - Category: Physics Authors: Matthew C Ward Abram Recht Frank Vicini Zahraa Al-Hilli Wafa Asha Manjeet Chadha Abel Abraham Nikhil Thaker Atif J Khan Martin Keisch Chirag Shah Source Type: research
More News: Arimidex | Breast Cancer | Breast Carcinoma | Breast Lumpectomy | Cancer | Cancer & Oncology | Carcinoma | Ductal Carcinoma | Endocrine Therapy | Hormones | Lumpectomy | Physics | Radiation Therapy | Women